North Texas Angel Network (NTAN) has invested $125,000 in Glidance Inc., marking a significant step in advancing autonomous mobility aids for individuals with vision impairments.

Information on the Target

Glidance Inc. is a pioneering technology company dedicated to enhancing the independence of individuals with vision impairments. The firm has developed Glide, the world’s first autonomous, self-guided mobility aid that assists those who are blind or have low vision in navigating their surroundings. By integrating advancements in artificial intelligence and robotics, Glide detects obstacles and maneuverers seamlessly, providing a user-friendly alternative to traditional mobility aids such as canes and guide dogs. Founded by Amos Miller, who lost his eyesight in his twenties, Glidance combines personal experience with cutting-edge technology, positioning itself as a leader in the mobility aid sector.

The innovative technology behind Glide aims to empower users to navigate both familiar and new environments effortlessly, ensuring them a greater sense of freedom and independence. The product has already received positive feedback from beta testers and has garnered several awards due to its unique approach to mobility assistance.

Industry Overview in the Target’s Specific Country

The assistive technology industry in the United States is experiencing significant growth, driven by advances in robotics, AI, and the increasing recognition of the needs of individuals with disabilities. According to

View Source

Similar Deals

SC Launch Inc. NeuroQuest

2025

Seed Stage In-Vivo Diagnostic & Testing Substances United States of America
Meharry Medical College eight medical clinics previously owned by Sanitas Medical Centers

2025

Seed Stage Hospitals, Clinics & Primary Care Services United States of America
Olympus Corporation Swan EndoSurgical

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) United States of America
Las Olas Venture Capital VetVerifi Inc.

2025

Seed Stage Veterinary Services United States of America
New World Angels Epion Therapeutics

2025

Seed Stage Bio Medical Devices United States of America
GPG Ventures Affineon Health

2025

Seed Stage Healthcare Facilities & Services (NEC) United States of America

North Texas Angel Network (NTAN)

invested in

Glidance Inc.

in 2025

in a Seed Stage deal

Disclosed details

Transaction Size: $0M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert